Format

Send to

Choose Destination
Biol Psychiatry. 2015 Dec 1;78(11):775-85. doi: 10.1016/j.biopsych.2015.03.030. Epub 2015 Apr 11.

Altered expression of CDC42 signaling pathway components in cortical layer 3 pyramidal cells in schizophrenia.

Author information

1
Departments of Neuroscience, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
2
Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
3
Department of Applied Genomics (JPC), Bristol-Myers Squibb, New York, New York.
4
Departments of Neuroscience, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania; Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. Electronic address: lewisda@upmc.edu.

Abstract

BACKGROUND:

Cognitive dysfunction in schizophrenia is associated with a lower density of dendritic spines on deep layer 3 pyramidal cells in the dorsolateral prefrontal cortex (DLPFC). These alterations appear to reflect dysregulation of the actin cytoskeleton required for spine formation and maintenance. Consistent with this idea, altered expression of genes in the cell division cycle 42 (CDC42)-CDC42 effector protein (CDC42EP) signaling pathway, a key organizer of the actin cytoskeleton, was previously reported in DLPFC gray matter from subjects with schizophrenia. We examined the integrity of the CDC42-p21-activated serine/threonine protein kinases (PAK)-LIM domain-containing serine/threonine protein kinases (LIMK) signaling pathway in schizophrenia in a layer-specific and cell type-specific fashion in DLPFC deep layer 3.

METHODS:

Using laser microdissection, samples of DLPFC deep layer 3 were collected from 56 matched pairs of subjects with schizophrenia and comparison subjects, and levels of CDC42-PAK-LIMK pathway messenger RNAs were measured by quantitative polymerase chain reaction. These same transcripts also were quantified by microarray in samples of individually microdissected deep layer 3 pyramidal cells from a subset of the same subjects and from monkeys exposed to antipsychotics.

RESULTS:

Relative to comparison subjects, CDC42EP4, LIMK1, LIMK2, ARHGDIA, and PAK3 messenger RNA levels were significantly upregulated in subjects with schizophrenia in laminar and cellular samples. In contrast, CDC42 and PAK1 messenger RNA levels were significantly downregulated specifically in deep layer 3 pyramidal cells. These differences were not attributable to psychotropic medications or other comorbid factors.

CONCLUSIONS:

Findings from the present and prior studies converge on synergistic alterations in CDC42 signaling pathway that could destabilize actin dynamics and produce spine deficits preferentially in deep layer 3 pyramidal cells in schizophrenia.

KEYWORDS:

Actin cytoskeleton; CDC42; Dendritic spine; Prefrontal cortex; Schizophrenia; mRNA

Comment in

PMID:
25981171
PMCID:
PMC4600637
DOI:
10.1016/j.biopsych.2015.03.030
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center